ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.742,22
-0,08%
S&P 500
5.221,42
-0,02%
Dow Jones
39.431,51
-0,21%
Euro vs US Dollar
1,07895
0,18%
Bitcoin
62.881,17
2,33%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Novavax Inc (NVAX)

  7. Novavax Inc (NVAX) News

NVAX

Novavax (NVAX)

Novavax Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:NVAX
DatumZeitQuelleÜberschriftSymbolFirma
13/05/202422h10Edgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:NVAXNovavax Inc
13/05/202422h02PR Newswire (US)Novavax to Participate in BofA Securities 2024 Health Care ConferenceNASDAQ:NVAXNovavax Inc
13/05/202420h39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
10/05/202414h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
10/05/202414h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVAXNovavax Inc
10/05/202414h02IH Market NewsNovavax Surges 57% Post $1.4 Billion Sanofi Deal; Apple Boosts Data Centers with AI and Internal Chips, and More NewsNASDAQ:NVAXNovavax Inc
10/05/202408h15PR Newswire (US)Novavax Reports First Quarter 2024 Financial Results and Operational HighlightsNASDAQ:NVAXNovavax Inc
10/05/202408h00PR Newswire (US)Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination VaccinesNASDAQ:NVAXNovavax Inc
08/05/202422h53Edgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:NVAXNovavax Inc
07/05/202423h21Edgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:NVAXNovavax Inc
07/05/202420h43Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:NVAXNovavax Inc
07/05/202415h25PR Newswire (US)Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational Highlights on May 10, 2024NASDAQ:NVAXNovavax Inc
07/05/202413h44IH Market NewsTesla’s April Sales Down 18% in China, Amazon’s Multi-Billion Dollar Cloud Expansion in Singapore, and More NewsNASDAQ:NVAXNovavax Inc
06/05/202422h43Edgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:NVAXNovavax Inc
06/05/202412h22GlobeNewswire Inc.Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual MeetingNASDAQ:NVAXNovavax Inc
15/04/202412h00GlobeNewswire Inc.Shah Capital nominates two highly qualified independent director candidates for NovavaxNASDAQ:NVAXNovavax Inc
01/04/202414h00PR Newswire (US)Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024NASDAQ:NVAXNovavax Inc
06/03/202401h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
29/02/202422h02PR Newswire (US)Novavax to Participate in TD Cowen's 44th Annual Health Care ConferenceNASDAQ:NVAXNovavax Inc
28/02/202414h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
28/02/202414h00PR Newswire (US)Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational HighlightsNASDAQ:NVAXNovavax Inc
28/02/202413h30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NVAXNovavax Inc
23/02/202414h03IH Market NewsGoldman Sachs Reconsiders Fed Cuts, LUNR Surges Over 40% in Pre-Market, and MoreNASDAQ:NVAXNovavax Inc
22/02/202412h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
22/02/202412h00PR Newswire (US)Novavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine Advance Purchase AgreementNASDAQ:NVAXNovavax Inc
20/02/202415h25PR Newswire (US)Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024NASDAQ:NVAXNovavax Inc
31/01/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
25/01/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
08/01/202415h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
03/01/202415h25PR Newswire (US)Novavax to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:NVAXNovavax Inc
 Showing the most relevant articles for your search:NASDAQ:NVAX

Kürzlich von Ihnen besucht

EU
CTAC
Ctac NV
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten